Kiran Mazumdar-Shaw picks niece Claire Mazumdar as successor at Biocon: Report

Claire Mazumdar, 37 years of age, currently heads Bicara Therapeutics as its founder and CEO. The firm, which was incubated by Biocon and later listed on NASDAQ, went public in 2024 and now has a market valuation of over $1.6 billion.

More From Author

<div>Mother’s Day Menus Across India: The Best Places to Take Mum Out This Sunday</div>

<div>Sunil Gavaskar Gives Big “Rohit Sharma” Warning To Other Teams As MI Beat LSG</div>

Leave a Reply